x

Global Erectile Dysfunction Drugs Market Professional Survey Report 2019

Published Date: 2019-07-23   |   Pages: 106   |   Tables: 121   | Report Id: 1222972   | Hits: 124 |   Pharma & Healthcare

category cover


Erectile dysfunction (ED), also known as impotence, is a type of sexual dysfunction characterized by the inability to develop or maintain an erection of the penis during sexual activity. Erectile dysfunction can have psychological consequences as it can be tied to relationship difficulties and self-image.

The classification of Erectile Dysfunction Drugs includes Sildenafil, Tadalafil and others, and the proportion of Sildenafil in 2018 is about 99.85%, and the proportion is in decreasing trend from 2014 to 2018.Erectile Dysfunction Drugs is widely used through Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-Commerce (B2B) and E-Commerce (B2C). The most proportion of Erectile Dysfunction Drugs is used for Hospital Pharmacies, and the sales proportion in 2018 is 29.24%.North America is the largest consumption place, with a consumption market share nearly 39.05% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 30.52%. Despite of increasing demand for erectile dysfunction drugs, this market is going to experience a decline in forecast period due to patent expiration of major brands. On the contrary, it will provide the key opportunity for generic manufacturers to enter the market. Generic drugs are the promising opportunity for this market.


The global Erectile Dysfunction Drugs market was valued at 5042.6 million US$ in 2018 and will reach 6583.3 million US$ by the end of 2025, growing at a CAGR of 6.0% during 2019-2025.

This report focuses on Erectile Dysfunction Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Erectile Dysfunction Drugs market size by analyzing historical data and future prospect.

Regionally, this report categorizes the production, apparent consumption, export and import of Erectile Dysfunction Drugs in North America, Europe, China, Japan, Southeast Asia and India.

For each manufacturer covered, this report analyzes their Erectile Dysfunction Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.


The following manufacturers are covered:

Eli Lilly

Pfizer

Bayer

BaiYunShan General Factory

S.K. Chemicals

Teva Pharma

Dong-A ST

Metuchen Pharma

Seoul Pharma

CSBIO.


Segment by Regions

North America

Europe

China

South Korea

Israel


Segment by Type

Sildenafil

Tadalafil

Others


In 2018, Sildenafil accounted for a major share of 56% in the global Erectile Dysfunction Drugs market. And this product segment is poised to reach 3366.84 M USD by 2025 from 2483.77 M USD in 2019.


Segment by Application

Hospital Pharmacies

Private Clinics

Retail Pharmacies

E-Commerce (B2B)

E-Commerce (B2C)


In Erectile Dysfunction Drugs market, Hospital Pharmacies segment holds an important share in terms of application, and it is expected to reach a volume of 458.57 (M Pill) by 2025, at a CAGR of 12.63% during 2018 and 2025. It means that Erectile Dysfunction Drugs will be promising in the Hospital Pharmacies field in the next couple of years.

Licenses Type

Only one user can access the report
Multiple users can access the report

Why QYR

 Fastest report delivery service
 More than 10 years of vast experience
 Operational for 24 * 7 & 365 days
 In-depth and comprehensive analysis
 Excellent after sales support
 Owns large database

Need Help ?

Global Erectile Dysfunction Drugs market

QYR Clients

  • csl
  • croozer
  • crital alert
  • cristal
  • corveneng
  • coperion
  • contijpi medical
  • compass minerals
More Clients...